Feb 3 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2016 Dec 31, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 511 mln 484 mln 800 mln
(+5.6 pct) (+12.1 pct) (+11.5 pct)
Operating loss 183 mln loss 101 mln loss 180 mln
Recurring loss 195 mln loss 98 mln loss 180 mln
Net loss 199 mln loss 35 mln loss 190 mln
EPS loss 27.41 yen loss 5.44 yen loss 28.14 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T
((Tokyo Headline News Desk +813 6441 1812))